Hangzhou Alltest Biotech Co., Ltd.
SHH: 688606.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Fei Gao
- Employees
- 1,093
- Headquarters
- Hangzhou, China
- IPO year
- 2021
- Market cap
- CN¥4.5B
- Website
- https://www.alltests.com.cn
Loading 688606…
Loading profile data…Frequently asked questions about 688606
What does Hangzhou Alltest Biotech Co., Ltd. (688606.SS) do?
Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and market of in vitro diagnostic reagents worldwide. It offers rapid diagnostic products, including women's health, infectious diseases, drugs, cancer, cardiovascular, and other five series of products. The company is based in Hangzhou, China.
Where does 688606.SS trade?
Hangzhou Alltest Biotech Co., Ltd. (688606.SS) trades on the Shanghai Stock Exchange.
What sector is 688606.SS in?
Hangzhou Alltest Biotech Co., Ltd. (688606.SS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Hangzhou Alltest Biotech Co., Ltd.?
Fei Gao is the chief executive officer of Hangzhou Alltest Biotech Co., Ltd. (688606.SS).
Where is Hangzhou Alltest Biotech Co., Ltd. headquartered?
Hangzhou Alltest Biotech Co., Ltd. is headquartered in China.
Does 688606.SS pay a dividend?
Yes — Hangzhou Alltest Biotech Co., Ltd. (688606.SS) paid a trailing twelve-month dividend of CNY 2.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688606.SS go public?
Hangzhou Alltest Biotech Co., Ltd. (688606.SS) completed its initial public offering in 2021.